Zobrazeno 1 - 10
of 106
pro vyhledávání: '"Peter, Steinherz"'
Autor:
Sabine Topka, Joseph Vijai, Michael F Walsh, Lauren Jacobs, Ann Maria, Danylo Villano, Pragna Gaddam, Gang Wu, Rose B McGee, Emily Quinn, Hiroto Inaba, Christine Hartford, Ching-Hon Pui, Alberto Pappo, Michael Edmonson, Michael Y Zhang, Polina Stepensky, Peter Steinherz, Kasmintan Schrader, Anne Lincoln, James Bussel, Steve M Lipkin, Yehuda Goldgur, Mira Harit, Zsofia K Stadler, Charles Mullighan, Michael Weintraub, Akiko Shimamura, Jinghui Zhang, James R Downing, Kim E Nichols, Kenneth Offit
Publikováno v:
PLoS Genetics, Vol 11, Iss 6, p e1005262 (2015)
Somatic mutations affecting ETV6 often occur in acute lymphoblastic leukemia (ALL), the most common childhood malignancy. The genetic factors that predispose to ALL remain poorly understood. Here we identify a novel germline ETV6 p. L349P mutation in
Externí odkaz:
https://doaj.org/article/857b67bb97a141dd80ae77fd0dd250d4
Autor:
Christopher J, Forlenza, Yanming, Zhang, JinJuan, Yao, Ryma, Benayed, Peter, Steinherz, Kavitha, Ramaswamy, Rachel, Kessel, Mikhail, Roshal, Neerav, Shukla
Publikováno v:
Cold Spring Harbor Molecular Case Studies
Acute megakaryoblastic leukemia (AMKL) constitutes ∼5%–15% of cases of non–Down syndrome AML in children, and in the majority of cases, chimeric oncogenes resulting from recurrent gene rearrangements are identified. Based on these rearrangement
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f98719858ae5257c2d8b5f7c2c8e0a78
https://pubmed.ncbi.nlm.nih.gov/30455225
https://pubmed.ncbi.nlm.nih.gov/30455225
Autor:
Sima Jeha, Bassem Razzouk, Michael Rytting, Susan Rheingold, Edythe Albano, Richard Kadota, Lori Luchtman-Jones, Lisa Bomgaars, Paul Gaynon, Stewart Goldman, Kim Ritchey, Robert Arceci, Arnold Altman, Kimo Stine, Laurel Steinherz, Peter Steinherz
Publikováno v:
Journal of Clinical Oncology. 27:4392-4397
Purpose To determine the efficacy and safety of clofarabine in pediatric patients with refractory or relapsed acute myeloid leukemia (AML). Patients and Methods A phase II, open-label, multicenter study was conducted with single-agent clofarabine in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0fe0c6cd9bcddb160f161989241fd7eb
https://doi.org/10.1200/jco.2008.18.8706
https://doi.org/10.1200/jco.2008.18.8706
Autor:
Nana Yaa, Mensah, Mensah Nana, Yaa, Paolo, Peterlongo, Peterlongo, Paolo, Peter, Steinherz, Steinherz, Peter, Eric G, Pamer, Pamer G, Eric, Jaya, Satagopan, Satagopan, Jaya, Genovefa Anna, Papanicolaou
Publikováno v:
Biology of Blood and Marrow Transplantation. 15(9):1130-1133
The Toll-like receptor 4 (TLR4) gene is a major recognition receptor for lipopolysaccharide (LPS). In a pilot prospective study, we examined the association of 2 TLR4 polymorphisms (Asp299Gly and Thr399Ile) in the donor or the recipient with Gram-neg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d2115e534090dc3cac12fedf2f2d211
Autor:
Sima Jeha, Paul S. Gaynon, Bassem I. Razzouk, Janet Franklin, Richard Kadota, Violet Shen, Lori Luchtman-Jones, Michael Rytting, Lisa R. Bomgaars, Susan Rheingold, Kim Ritchey, Edythe Albano, Robert J. Arceci, Stewart Goldman, Timothy Griffin, Arnold Altman, Bruce Gordon, Laurel Steinherz, Steven Weitman, Peter Steinherz
Publikováno v:
Journal of Clinical Oncology. 24:1917-1923
Purpose To evaluate the efficacy and safety of clofarabine, a novel deoxyadenosine analog, in pediatric patients with refractory or relapsed acute lymphoblastic leukemia (ALL). Patients and Methods In a phase II, open-label, multicenter study, 61 ped
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::000874592f4b52aa9574002bf4de2091
https://doi.org/10.1200/jco.2005.03.8554
https://doi.org/10.1200/jco.2005.03.8554
Autor:
Neerav, Shukla, Rachel, Kobos, Thomas, Renaud, Julie, Teruya-Feldstein, Anita, Price, Linda, McAllister-Lucas, Peter, Steinherz
Publikováno v:
Cancer. 118(15)
Histiocytic sarcoma (HS) is an exceedingly rare tumor and carries a dismal prognosis when patients present with advanced-stage disease. Because of the poor response rates to conventional chemotherapy and the rarity of the disease, no standard of care
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0ca628428a6d82d99217be2ee7b21f44
https://pubmed.ncbi.nlm.nih.gov/22170006
https://pubmed.ncbi.nlm.nih.gov/22170006
Publikováno v:
Journal of pediatric surgery. 42(9)
The National Wilms Tumor Study currently describes 3 indications for the use of preoperative chemotherapy: extensive caval involvement, bilateral tumors, and patients who only have a single kidney. However, the management of patients who present with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab2f6b4ab80c821db006edf5f2ba890d
https://pubmed.ncbi.nlm.nih.gov/18280305
https://pubmed.ncbi.nlm.nih.gov/18280305
Autor:
Yaa, Mensah Nana, Paolo, Peterlongo, Peter, Steinherz, Eric, Pamer G., Jaya, Satagopan, Papanicolaou, Genovefa Anna
Publikováno v:
In Biology of Blood and Marrow Transplantation 2009 15(9):1130-1133
Autor:
Mensah NY; Department of Medicine, Service of Infectious Disease, Memorial Sloan-Kettering Cancer Center, New York, New York, USA., Peterlongo P, Steinherz P, Pamer EG, Satagopan J, Papanicolaou GA
Publikováno v:
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation [Biol Blood Marrow Transplant] 2009 Sep; Vol. 15 (9), pp. 1130-3. Date of Electronic Publication: 2009 Jun 26.
Autor:
Isabelle Rapin, Peter Steinherz
Publikováno v:
Journal of speech and hearing research. 13(1)
A substantial part of reaction time (RT), the time elapsed between presentation of a stimulus and the subject’s response, reflects a central delay during which the brain processes the input and elaborates a response. Low stimulus intensity, ineffic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16ba86f9ea4ef7f58108d0de1fb56f15
https://pubmed.ncbi.nlm.nih.gov/5421134
https://pubmed.ncbi.nlm.nih.gov/5421134